Bicocca Open Archive

Logo unimib boa
GRASSI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 115.964
AS - Asia 57.666
EU - Europa 41.258
SA - Sud America 8.233
Continente sconosciuto - Info sul continente non disponibili 3.731
AF - Africa 1.310
OC - Oceania 155
Totale 228.317
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 109.188
SG - Singapore 20.774
CN - Cina 11.153
IT - Italia 9.885
VN - Vietnam 8.588
HK - Hong Kong 8.247
RU - Federazione Russa 6.728
BR - Brasile 6.136
SE - Svezia 6.095
CA - Canada 5.599
DE - Germania 4.385
IE - Irlanda 3.810
UA - Ucraina 2.748
GB - Regno Unito 2.014
BD - Bangladesh 1.891
FR - Francia 1.819
IN - India 1.435
FI - Finlandia 1.042
KR - Corea 898
AR - Argentina 736
TR - Turchia 683
ID - Indonesia 680
IQ - Iraq 557
AT - Austria 508
MX - Messico 481
NL - Olanda 409
PK - Pakistan 402
ZA - Sudafrica 400
EC - Ecuador 347
JP - Giappone 343
ES - Italia 331
PL - Polonia 312
SA - Arabia Saudita 293
CO - Colombia 292
PH - Filippine 286
VE - Venezuela 229
DK - Danimarca 209
UZ - Uzbekistan 188
MY - Malesia 171
JM - Giamaica 146
CL - Cile 141
MA - Marocco 134
PY - Paraguay 131
AU - Australia 128
EG - Egitto 126
KE - Kenya 125
TN - Tunisia 123
BE - Belgio 120
CR - Costa Rica 111
AE - Emirati Arabi Uniti 102
CZ - Repubblica Ceca 102
TH - Thailandia 91
PE - Perù 90
TW - Taiwan 90
JO - Giordania 86
ET - Etiopia 80
NP - Nepal 77
IR - Iran 74
PT - Portogallo 71
CH - Svizzera 68
RO - Romania 68
LT - Lituania 67
KZ - Kazakistan 65
GR - Grecia 64
HN - Honduras 62
UY - Uruguay 60
AZ - Azerbaigian 59
DZ - Algeria 58
TT - Trinidad e Tobago 58
LB - Libano 56
BO - Bolivia 52
EU - Europa 50
PS - Palestinian Territory 49
AL - Albania 47
BG - Bulgaria 47
NI - Nicaragua 47
DO - Repubblica Dominicana 46
NG - Nigeria 46
EE - Estonia 43
GT - Guatemala 42
IL - Israele 42
OM - Oman 42
SN - Senegal 40
SV - El Salvador 39
PA - Panama 37
HU - Ungheria 36
KG - Kirghizistan 34
RS - Serbia 33
BH - Bahrain 29
NO - Norvegia 29
PR - Porto Rico 29
BY - Bielorussia 28
SK - Slovacchia (Repubblica Slovacca) 23
SY - Repubblica araba siriana 22
BA - Bosnia-Erzegovina 21
LK - Sri Lanka 21
LV - Lettonia 21
NZ - Nuova Zelanda 21
CI - Costa d'Avorio 20
MU - Mauritius 20
Totale 224.181
Salva come PNG Salva come JPEG
Città #
Ann Arbor 12.308
Singapore 10.852
Ashburn 9.783
Hong Kong 8.118
Fairfield 6.271
Woodbridge 6.108
San Jose 5.785
Houston 4.699
Toronto 4.223
Dublin 3.632
Chandler 3.323
Milan 3.257
Wilmington 2.910
Jacksonville 2.881
Seattle 2.695
New York 2.636
Ho Chi Minh City 2.567
Frankfurt am Main 2.490
Dallas 2.110
Hanoi 2.061
Dearborn 2.035
Cambridge 2.018
Stockholm 1.965
Chicago 1.872
Santa Clara 1.830
Council Bluffs 1.796
Princeton 1.663
Hefei 1.654
Los Angeles 1.559
Beijing 1.490
The Dalles 1.421
Rome 981
Lauterbourg 904
Seoul 835
Lawrence 782
Moscow 727
Altamura 724
Nanjing 704
Boardman 673
Buffalo 600
São Paulo 548
Shanghai 513
San Diego 509
Lachine 461
Hangzhou 455
Phoenix 407
Helsinki 397
Atlanta 392
Vienna 378
Orem 361
Jakarta 353
Da Nang 335
Guangzhou 334
Columbus 300
Haiphong 282
Andover 277
Munich 277
London 271
Brooklyn 268
Denver 251
Nanchang 246
Baghdad 239
San Francisco 239
Figino 232
Tokyo 232
Salt Lake City 212
Shenyang 210
Montreal 198
Warsaw 197
Changsha 191
Hebei 191
Dong Ket 189
Rio de Janeiro 189
Ottawa 183
Tianjin 180
Nuremberg 179
Philadelphia 177
Turin 171
Istanbul 161
Tashkent 160
Chennai 158
Washington 156
Johannesburg 155
Jiaxing 143
Jinan 141
Falls Church 140
Brasília 135
Naples 135
Biên Hòa 131
Boston 131
Miami 129
Tampa 129
Dhaka 128
Hải Dương 128
Norwalk 128
Quito 120
Mumbai 119
Can Tho 116
Lahore 116
Lissone 116
Totale 138.941
Salva come PNG Salva come JPEG
Nome #
Behaviour of regional adrenergic outflow in mild-to-moderate renal failure 2.083
Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA) 990
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 880
Assessment and management of exaggerated blood pressure response to standing and orthostatic hypertension: consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability 830
Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH Guidelines 775
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension 765
The Sympathetic Nervous System in Hypertension: Roadmap Update of a Long Journey 675
Dual renin-angiotensin systemblockade and vascular remodeling: Is this a real advantage for vascular protection? 629
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 626
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 624
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: Morphological criteria and clinical impact 570
Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis 563
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 522
Sex-related relationships between uric acid and target organ damage in hypertension 514
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 505
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 504
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 496
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 491
Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 1: overview and the central role for catecholamines and sympathetic nervous system 482
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 473
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology? 468
Big data, observational research and P-value: a recipe for false-positive findings? A study of simulated and real prospective cohorts 463
Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials 454
Heart rate as a sympathetic marker during acute adrenergic challenge 452
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 438
Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension 415
Early alterations in left ventricular diastolic function in normotensive diabetic patients 408
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 408
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 405
Persistence of arterial functional abnormalities after successful coronary revascularization 404
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 404
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity 403
Calcium antagonists and neural control of circulation in essential hypertension 400
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals 400
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 395
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 394
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 394
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 389
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 388
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 387
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium 386
Differing associations for sport versus occupational physical activity and cardiovascular risk 385
A case of Pseudomonas Aeruginosa commercial tattoo infection 380
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 380
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 378
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury 368
Statins and the risk of diabetes: Evidence from a large population-based cohort study 367
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 366
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 364
Reflex cardiovascular control in congestive heart failure 361
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 358
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 357
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 354
Flavanol-rich cocoa at breakfast: The right remedy after a sleepless night to prevent negative effects on blood pressure and cognition? 351
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 351
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 349
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 347
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 347
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 347
Heart rate as cardiovascular risk factor 347
Historical Archive of Blood Pressure and Evolution of Hypertension 346
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 345
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 345
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 344
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis 344
The Pamela study: main findings and perspectives 343
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 343
Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period 342
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period. 342
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 341
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 340
Cardiopulmonary receptor regulation of renin release 339
Exploring the interplay between job strain and different domains of physical activity on the incidence of coronary heart disease in adult men 338
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 337
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 336
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 334
Pulse wave velocity progressione over a 3.7 years follow-up: focus on metabolic syndrome. 332
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 331
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 330
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 329
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 328
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 327
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 325
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 325
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 324
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 324
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 322
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 322
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 322
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 321
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension 320
Comparison between non-invasive and invasive pulse wave velocity assessment in human beings 320
Neurogenic abnormalities in masked hypertension 319
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 319
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 319
Prognostic significance of masked tachycardia in hypertension: Evidence from a prospective international registry 317
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 316
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 315
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 315
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 314
Totale 42.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 746.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 746.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.900 0 0 0 930 814 744 526 679 638 762 978 1.829
2022/202314.314 2.112 4.076 1.131 1.153 862 2.360 194 817 889 109 400 211
2023/202411.472 322 293 482 532 1.772 2.742 2.129 325 1.204 226 212 1.233
2024/202531.683 1.760 3.941 1.278 1.366 2.575 926 1.539 1.204 3.523 4.124 3.456 5.991
2025/202680.996 8.086 5.966 5.890 7.638 7.574 3.917 9.810 3.526 5.925 8.153 7.167 7.344
2026/202724.385 3.778 5.732 9.501 5.374 0 0 0 0 0 0 0 0
Totale 228.317